The off-label application without specific FDA approval for non-diabetic patients raises regulatory and safety concerns
Patients wanting insurance coverage for branded GLP-1s will not find it here
In April, FDA officials gave the green light to Foundayo, an oral tablet manufactured by Eli Lilly, which is also used for weight management
From a peptide engineering perspective, this compound serves as a valuable model for studying long-chain peptide stability, solubility behavior, and structureactivity relationships
Fasting glucose is checked because GH can transiently affect insulin sensitivity, and a patient with prediabetes or undiagnosed metabolic syndrome requires a different clinical conversation
Who it's for: Patients with toxic exposure, chronic inflammation, or conditions where cellular damage may be contributing